I think that Marc-André has characterized it well. Clearly, some organization, I would argue, at a national level, the federal level, should keep track of the drugs that Canadians are getting and properly link those to side effects that they're experiencing, because both marketing and surveillance is a huge problem.
I agree with Marc-André that it's even worse around medical devices. We very much need the federal government to be involved in ensuring that there are registries for joints, heart valves, and other products at the very least, to ensure that we're tracking what people have inside of them. That's the very least we can expect from the federal government.